New Funding Infrastructure for a Changing Research Economy
BioCrowd is an institutional research funding platform that helps hospitals, universities, and patient communities raise milestone-based capital when traditional grants fall short.
As federal funding becomes less predictable, institutions need new, compliant capital sources. BioCrowd provides clinical research funding infrastructure that unlocks Donor-Advised Funds, venture philanthropy, and impact investing in biotech.
The Problem: A Growing Clinical Research Funding Crisis
NIH funding uncertainty is creating a widening capital gap across clinical and translational research.
Institutions are experiencing:
- Delayed or cancelled clinical trials
- Fewer early-stage translational programs
- Increasing reliance on alternative funding sources
BioCrowd was built to address this clinical research funding crisis by connecting institutions with new capital sources.
The BioCrowd Capital Layer
BioCrowd is the capital-raising layer that sits between advancement, tech transfer, and research administration systems.
BioCrowd is:
- An alternative capital source alongside NIH and foundation grants
- A specialized platform for translational research, not general fundraising
- An R1 and R2 university & hospital research funding SaaS
- A purpose-built capital marketplace for research-driven spinouts
- A venture philanthropy platform for biotech
- A capital layer feeding trials already managed in CTMS
- Financial rails tied to milestone data from existing research systems
- A funding marketplace for the tech transfer pipeline
- An external funding layer that feeds approved capital into ERP systems
- Capital aligned to datasets and patient cohorts
- Funding released only after IRB-approved milestones
Capital Sources BioCrowd Unlocks
BioCrowd helps institutions raise:
- Donor-Advised Fund capital
- Venture philanthropy funding
- Impact investor capital
- Compliant biotech SAFE investments
Core Value Proposition
BioCrowd connects:
Institution-led research → milestone funding → defensible IP → licensing or acquisition → investor returns
Research Institutions
Accelerate your research funding with our innovation platform designed specifically for academic research institutions and hospital health systems.
What You Get
Raise Capital from Untapped Donor Segments.
Discover new tools and channels for capital investment
Project Management
Streamlined submission and tracking of research projects
Milestone Tracking
Real-time progress monitoring with blockchain verification
Team Collaboration
Collaborative workspace for research teams and stakeholders
Compliance Management
Built-in regulatory compliance and reporting tools
Funding Analytics
Comprehensive insights into funding performance and trends
Global Network
Access to international funding opportunities and partnerships
Trusted by Research-Driven Institutions
BioCrowd is designed specifically for academic medical centers, R1, R2 university research programs, and hospital-based research organizations seeking compliant, transparent alternatives to traditional NIH grant funding.
Donors & Investors
Discover high-impact biomedical research opportunities and track your investments with unprecedented transparency and control.
What You Get
Project Discovery
AI-powered matching with high-potential research projects
Portfolio Dashboard
Comprehensive view of all investments and performance metrics
Real-time Updates
Instant notifications on project milestones and progress
Risk Assessment
Advanced analytics for investment risk evaluation
Impact Measurement
Track social and scientific impact of your investments
Secure Transactions
Bank-grade security with blockchain transparency
Donate or Invest
Accredited investors may elect to receive alerts regarding institution supported investment opportunities, where offered, including SAFE-Note based or SPV structures linked to research programs.
Or donate for a tax deduction and self-direct what lab, disease, researcher or institution you want your donation to go to.
BioCrowd Featured Projects
$250,000
CancerThe Role of Cancer Stem Cells in Cancer Treatment
$500,000
NeurologyResearch on Neuropsychiatric Disorder
$370,000
ImmunologyActive immunotherapy for acute lymphoblastic leukemia
$850,000
Rare DiseasesResearch on Nephropathic Cystinosis
$550,000
LongevityThe Real Science behind the Billionaire Pursuit of Immortality
$900,000
Cancer